Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020
Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected or treated quickly. NBS continues to be one of the...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2023-04-01
|
| Series: | International Journal of Neonatal Screening |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2409-515X/9/2/23 |
| _version_ | 1797594217038479360 |
|---|---|
| author | Amy Gaviglio Sarah McKasson Sikha Singh Jelili Ojodu |
| author_facet | Amy Gaviglio Sarah McKasson Sikha Singh Jelili Ojodu |
| author_sort | Amy Gaviglio |
| collection | DOAJ |
| description | Newborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected or treated quickly. NBS continues to be one of the most successful public health interventions in the US, providing early detection and intervention to all infants. The increase in overall birth prevalence of core Recommended Uniform Screening Panel (RUSP) diseases detected via dried blood spot (DBS) specimens from 2015–2017 (17.50–18.31 per 10,000) to 2018–2020 (20.07 per 10,000), as reported into the APHL NewSTEPs database, affirms the importance and impact of NBS programs. This report presents aggregate numbers and birth prevalence of diseases detected by DBS on the RUSP from 2018–2020, including data from fifty US states and two territories. |
| first_indexed | 2024-03-11T02:20:31Z |
| format | Article |
| id | doaj.art-8ff2048102c74722bd7d2e95c49100af |
| institution | Directory Open Access Journal |
| issn | 2409-515X |
| language | English |
| last_indexed | 2024-03-11T02:20:31Z |
| publishDate | 2023-04-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | International Journal of Neonatal Screening |
| spelling | doaj.art-8ff2048102c74722bd7d2e95c49100af2023-11-18T10:53:15ZengMDPI AGInternational Journal of Neonatal Screening2409-515X2023-04-01922310.3390/ijns9020023Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020Amy Gaviglio0Sarah McKasson1Sikha Singh2Jelili Ojodu3Association of Public Health Laboratories, Silver Spring, MD 20910, USAAssociation of Public Health Laboratories, Silver Spring, MD 20910, USAAssociation of Public Health Laboratories, Silver Spring, MD 20910, USAAssociation of Public Health Laboratories, Silver Spring, MD 20910, USANewborn screening (NBS) is a state or territory-based public health system that screens newborns for congenital diseases that typically do not present with clinical symptoms at birth but can cause significant mortality and morbidity if not detected or treated quickly. NBS continues to be one of the most successful public health interventions in the US, providing early detection and intervention to all infants. The increase in overall birth prevalence of core Recommended Uniform Screening Panel (RUSP) diseases detected via dried blood spot (DBS) specimens from 2015–2017 (17.50–18.31 per 10,000) to 2018–2020 (20.07 per 10,000), as reported into the APHL NewSTEPs database, affirms the importance and impact of NBS programs. This report presents aggregate numbers and birth prevalence of diseases detected by DBS on the RUSP from 2018–2020, including data from fifty US states and two territories.https://www.mdpi.com/2409-515X/9/2/23newborn screeningrare diseasebirth prevalence |
| spellingShingle | Amy Gaviglio Sarah McKasson Sikha Singh Jelili Ojodu Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 International Journal of Neonatal Screening newborn screening rare disease birth prevalence |
| title | Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 |
| title_full | Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 |
| title_fullStr | Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 |
| title_full_unstemmed | Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 |
| title_short | Infants with Congenital Diseases Identified through Newborn Screening—United States, 2018–2020 |
| title_sort | infants with congenital diseases identified through newborn screening united states 2018 2020 |
| topic | newborn screening rare disease birth prevalence |
| url | https://www.mdpi.com/2409-515X/9/2/23 |
| work_keys_str_mv | AT amygaviglio infantswithcongenitaldiseasesidentifiedthroughnewbornscreeningunitedstates20182020 AT sarahmckasson infantswithcongenitaldiseasesidentifiedthroughnewbornscreeningunitedstates20182020 AT sikhasingh infantswithcongenitaldiseasesidentifiedthroughnewbornscreeningunitedstates20182020 AT jeliliojodu infantswithcongenitaldiseasesidentifiedthroughnewbornscreeningunitedstates20182020 |